- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | 'One of the lucky few': Bicara's CEO on operating in today's market, while hoping for a different one | ||
| Mo | Ironwood rethinks options after FDA demands another phase 3 trial for GI drug | ||
| Mo | Third Harmonic's song to end as biotech looks to liquidate, sell off urticaria drug | ||
| Mo | Pfizer axes oral GLP-1 asset over liver injury, blowing hole in obesity plan | ||
| Mo | Verve Therapeutics' 2nd swing at PCSK9 editing yields clean safety profile, teeing up Lilly opt-in decision | ||
| Fr | Market volatility compounds 'already challenging' year for biotech IPOs | ||
| Fr | Time runs out for Kronos' headquarters amid wider cost-cutting exercise | ||
| Do | Biotech leaders urge Senate to restore FDA's key functions, cite funding concerns for small companies | ||
| Do | Pfizer shakes up R&D presence in San Diego with $255M site sale, 56 layoffs | ||
| Do | Alzheon Alzheimer's drug knocked down in pivotal APOLLOE4 bout | ||
| Do | Keros considers a sale, strengthens defense against potential activist investors | ||
| Do | Opthea lays off 65% of staff after back-to-back phase 3 eye disease flops | ||
| Do | Tempest, weathering stormy capital markets, hunts for partners for liver cancer drug | ||
| Mi | From ADCs to radiopharma: How AstraZeneca is trying to 'redefine oncology care' | ||
| Mi | Judge permanently blocks NIH grant caps, prompting HHS appeal | ||
| Mi | Vincerx's final merger attempt collapses, leaving ADC biotech to wind down | ||
| 08.04. | HHS cuts contract spend by 35%, with 334 pacts already terminated | ||
| 08.04. | Third Rock-backed Merida launches with $121M series A to fund autoimmune pipeline | ||
| 08.04. | J&J links FcRn blocker to sustained benefits as FDA ruling on potential blockbuster nears | ||
| 08.04. | Rallybio abandons lead program after phase 2 data in rare maternal disorder disappoint | ||
| 08.04. | KalVista, awaiting FDA call on HAE drug, sells Japanese rights to Kaken in $22M deal | ||
| 08.04. | Congressional commission urges action to maintain US biotech advantage over China | ||
| 07.04. | 'A slow-moving catastrophe': FDA cuts are like firing all hospital staff except doctors, Janet Woodcock says | ||
| 07.04. | Nordic Capital steps away from potential PureTech Health buyout | ||
| 07.04. | Lexeo locks in pivotal trial plan as clinical data pump up prospects of cardiac gene therapy |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
